Skip to main content

Medical Oncology

Ausgabe 9/2017

Inhalt (18 Artikel)

Original Paper

Amplification of EGFR and cyclin D1 genes associated with human papillomavirus infection in oral squamous cell carcinoma

Jureeporn Chuerduangphui, Chamsai Pientong, Natcha Patarapadungkit, Apinya Chotiyano, Patravoot Vatanasapt, Bunkerd Kongyingyoes, Supannee Promthet, Piyawut Swangphon, Sureewan Bumrungthai, Charinya Pimson, Tipaya Ekalaksananan

Original Paper

Predictors of recurrent hospital admissions among prostate cancer survivors

Jerome Gnanaraj, Zarish Umar, Shobana Balakrishnan, Lucia Ponor, Edward James Wright, Waseem Khaliq

Original Paper

Phase II study of paclitaxel associated with lipid core nanoparticles (LDE) as third-line treatment of patients with epithelial ovarian carcinoma

Silvia R. Graziani, Carolina G. Vital, Aleksandra T. Morikawa, Brigitte M. Van Eyll, Hezio J. Fernandes Junior, Roberto Kalil Filho, Raul C. Maranhão

Original Paper

Ten-year results of accelerated hypofractionated adjuvant whole-breast radiation with concomitant boost to the lumpectomy cavity after conserving surgery for early breast cancer

Domenico Cante, Edoardo Petrucci, Piera Sciacero, Cristina Piva, Silvia Ferrario, Silvia Bagnera, Sebastiano Patania, Guido Mondini, Massimo Pasquino, Valeria Casanova Borca, Giorgio Vellani, Maria Rosa La Porta, Pierfrancesco Franco

Original Paper

A comparative study of Ki-67 antigen expression between luminal A and triple-negative subtypes of breast cancer

Umbelina Soares Borges, Danylo Rafhael Costa-Silva, João Paulo da Silva-Sampaio, Carla Solange Escórcio-Dourado, Airton Mendes Conde Jr., Viriato Campelo, Luiz Henrique Gebrim, Benedito Borges da Silva, Pedro Vitor Lopes-Costa

Original Paper

Tolerability and efficacy of concurrent chemoradiotherapy comparing carboplatin/paclitaxel versus platinum/5-FU regimen for locally advanced esophageal and esophagogastric junction cancers

Amorn Tamtai, Chuleeporn Jiarpinitnun, Pitichote Hiranyatheb, Nattawut Unwanatham, Eakapop Sirachainun, Chairat Supsamutchai, Poompis Pattaranutaporn, Nuttapong Ngamphaiboon

Original Paper

ZAR1 knockdown promotes the differentiation of human neuroblastoma cells by suppression of MYCN expression

Yosuke Watanabe, Yoshiaki Ishizuka, Takayuki Hirano, Eri Nagasaki-Maeoka, Reina Hoshi, Shinsuke Yoshizawa, Shota Uekusa, Hiroyuki Kawashima, Kiminobu Sugito, Kenichi Shinohara, Noboru Fukuda, Hiroki Nagase, Masayoshi Soma, Tsugumichi Koshinaga, Kyoko Fujiwara

Open Access Original Paper

Patient characteristics and overall survival in patients with post-docetaxel metastatic castration-resistant prostate cancer in the community setting

William K. Oh, Raymond Miao, Francis Vekeman, Jennifer Sung, Wendy Y. Cheng, Marjolaine Gauthier-Loiselle, Ravinder Dhawan, Mei Sheng Duh

Original Paper

Bcl-2 antigen expression in luminal A and triple-negative breast cancer

Carla Solange Escórcio-Dourado, Luana Mota Martins, Camila Maria Simplício-Revoredo, Fabiane Araújo Sampaio, Cléciton Braga Tavares, João Paulo da Silva-Sampaio, Umbelina Soares Borges, Francisco Adelton Alves-Ribeiro, Pedro Vitor Lopes-Costa, José Charles Lima-Dourado, Benedito Borges da Silva

Open Access Original Paper

High-dose 8% capsaicin patch in treatment of chemotherapy-induced peripheral neuropathy: single-center experience

Iwona Filipczak-Bryniarska, Roger M. Krzyzewski, Jakub Kucharz, Anna Michalowska-Kaczmarczyk, Justyna Kleja, Jarosław Woron, Katarzyna Strzepek, Lucyna Kazior, Jerzy Wordliczek, Tomasz Grodzicki, Krzysztof Krzemieniecki

Original Paper

Activity of cabazitaxel in patients with metastatic castration-resistant prostate cancer after treatment with single or dual regimens of novel androgen receptor-targeting agents

Yukari Bando, Nobuyuki Hinata, Tomoaki Terakawa, Junya Furukawa, Ken-ichi Harada, Yuzo Nakano, Masato Fujisawa

Review Article

Lung cancer as a cardiotoxic state: a review

David Pérez-Callejo, María Torrente, María Auxiliadora Brenes, Beatriz Núñez, Mariano Provencio

Review Article

Ovarian cancer recurrence and early detection: may HE4 play a key role in this open challenge? A systematic review of literature

Stella Capriglione, Daniela Luvero, Francesco Plotti, Corrado Terranova, Roberto Montera, Giuseppe Scaletta, Teresa Schirò, Gianmarco Rossini, Pierluigi Benedetti Panici, Roberto Angioli

Review Article

Optimizing tumor immune response through combination of radiation and immunotherapy

Alissar El Chediak, Ali Shamseddine, Larry Bodgi, Jean-Pierre Obeid, Fady Geara, Youssef H. Zeidan

Short Communication

Effect of a 12-week integrative oncology intervention on gastro-intestinal concerns in patients with gynecological and breast cancer undergoing chemotherapy

Ilanit Shalom-Sharabi, Lital Keinan-Boker, Noah Samuels, Ofer Lavie, Efraim Lev, Eran Ben-Arye

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.